Skeletal muscle myofibrillar mRNA expression in heart failure: relationship to local and circulating hormones
Authors:
- André TchernofATAndré Tchernof
Open Access
- 1 January 2006
- journal article
- research article
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 100 (1) , 35-41
Abstract
Chronic heart failure is characterized by changes in skeletal muscle that contribute to exercise intolerance and muscle weakness. To determine whether changes in the quantity and isoform distribution of key myofibrillar proteins are related to altered gene expression, we measured skeletal muscle myofibrillar mRNA abundance in nine heart failure patients (mean ± SE; 63 ± 3 yr) and nine controls (70 ± 3 yr). In addition, we assessed the relationship of circulating levels of anabolic and catabolic hormones, as well as local expression of insulin-like growth factor (IGF)-I, to myofibrillar mRNA abundance. Heart failure patients were characterized by lower abundance of mRNA encoding the myosin heavy chain (MHC) I isoform (P < 0.01), whereas MHC IIa and MHC IIx mRNA did not differ between groups. Actin mRNA was also lower in heart failure patients compared with controls (P < 0.001). The expression of each MHC isoform transcript correlated with its respective protein product (MHC I: r = 0.656, P < 0.01; MHC IIa: r = 0.489, P < 0.05; MHC IIx: r = 0.505, P < 0.05; n = 18 for all). In addition to changes in myofibrillar transcripts, we found lower (P < 0.01) skeletal muscle IGF-1Ea mRNA content in heart failure patients. Myofibrillar mRNA levels were positively associated with skeletal muscle IGF-1Ea transcript levels (range of r values: 0.663–0.765; P values: r values: −0.487 to −0.555; P values: <0.05 to <0.03). Our findings suggest that alterations in skeletal muscle MHC content and isoform distribution in heart failure may derive, in part, from changes in MHC gene expression. The relationships of myofibrillar mRNA content to both local and circulating hormones further suggest that alterations in the balance between anabolic and catabolic hormones in heart failure patients may influence skeletal muscle myofibrillar protein phenotype by altering gene expression.Keywords
This publication has 44 references indexed in Scilit:
- Genetic Loss of Calcineurin Blocks Mechanical Overload-induced Skeletal Muscle Fiber Type Switching but Not HypertrophyJournal of Biological Chemistry, 2004
- Beneficial effects of GH/IGF-1 on skeletal muscle atrophy and function in experimental heart failureAmerican Journal of Physiology-Cell Physiology, 2004
- ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: Summary ArticleCirculation, 2003
- Altered Skeletal Muscle Phenotypes in Calcineurin Aα and Aβ Gene-Targeted MiceMolecular and Cellular Biology, 2003
- Calcineurin regulates slow myosin, but not fast myosin or metabolic enzymes, during fast‐to‐slow transformation in rabbit skeletal muscle cell cultureThe Journal of Physiology, 2001
- Calcineurin Co-regulates Contractile and Metabolic Components of Slow Muscle PhenotypeJournal of Biological Chemistry, 2000
- Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failureEuropean Heart Journal, 1999
- Changes in muscle fibre type, muscle mass and IGF‐I gene expression in rabbit skeletal muscle subjected to stretchJournal of Anatomy, 1997
- Growth hormone (GH) and insulin-like growth factor-I (IGF-I) treatment of the GH-deficient dwarf rat: differential effects on IGF-I transcription start site expression in hepatic and extrahepatic tissues and lack of effect on type I IGF receptor mRNA expressionMolecular and Cellular Endocrinology, 1994
- Quatitative determination of myosin and actin in rabbit skeletal muscleJournal of Molecular Biology, 1983